Ken Griffin Spectrum Pharmaceuticals Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.65 - $1.31 $65 - $131	100 New	100 $0
Q4 2022 Feb 14, 2023	BUY	$0.32 - $0.52 $94,845 - $154,123	296,392 New	296,392 $109,000
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.4 $518,850 - $1.04 Million	741,215 Added 5327.5%	755,128 $589,000
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $316,263 - $798,189	-502,006 Reduced 97.3%	13,913 $18,000
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $629,391 - $1.2 Million	495,584 Added 2437.1%	515,919 $655,000
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $282,378 - $501,714	-131,339 Reduced 86.59%	20,335 $44,000
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $131,749 - $202,866	45,588 Added 42.97%	151,674 $568,000
Q1 2021 May 17, 2021	SELL	$2.9 - $4.09 $489,731 - $690,690	-168,873 Reduced 61.42%	106,086 $346,000
Q4 2020 Feb 16, 2021	SELL	$3.38 - $5.14 $438,237 - $666,431	-129,656 Reduced 32.04%	274,959 $937,000
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $730,832 - $1.17 Million	346,366 Added 594.63%	404,615 $1.37 Million
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $34,702 - $65,422	-18,963 Reduced 24.56%	58,249 $136,000
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $183,340 - $542,164	52,383 Added 210.98%	77,212 $281,000
Q3 2019 Nov 14, 2019	SELL	$7.03 - $9.7 $5.59 Million - $7.71 Million	-794,783 Reduced 96.97%	24,829 $206,000
Q2 2019 Aug 14, 2019	BUY	$7.36 - $11.26 $3.51 Million - $5.37 Million	476,983 Added 139.21%	819,612 $7.06 Million
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $1.47 Million - $1.92 Million	161,935 Added 89.62%	342,629 $0
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $8.88 Million - $23.6 Million	-1,390,037 Reduced 88.5%	180,694 $1.58 Million
Q3 2018 Nov 13, 2018	BUY	$16.52 - $24.82 $5.08 Million - $7.64 Million	307,667 Added 24.36%	1,570,731 $0
Q2 2018 Aug 10, 2018	BUY	$14.31 - $21.75 $17.3 Million - $26.2 Million	1,206,063 Added 2115.86%	1,263,064 $0
Q1 2018 May 11, 2018	SELL	$16.09 - $23.07 $410,504 - $588,584	-25,513 Reduced 30.92%	57,001 $917,000
Q3 2017 Nov 09, 2017	BUY	$8.75 - $14.07 $721,997 - $1.16 Million	82,514	82,514 $1.16 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account